Role of physicochemical properties in silica nanoparticle-mediated immunostimulation.

Autor: Grunberger JW; Utah Center for Nanomedicine, Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA., Newton HS; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, USA., Donohue D; Statistics Department, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, USA., Dobrovolskaia MA; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, USA., Ghandehari H; Utah Center for Nanomedicine, Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA.; Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, USA.

Publikováno v: Nanotoxicology [Nanotoxicology] 2024 Nov; Vol. 18 (7), pp. 599-617. Date of Electronic Publication: 2024 Oct 26.

Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles.

Autor: Newton HS; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Zhang J; Agilent Technologies, Santa Clara, CA, United States., Donohue D; Statistics Department, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Unnithan R; Statistics Department, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Cedrone E; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Xu J; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Vermilya A; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Malys T; Statistics Department, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Clogston JD; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Dobrovolskaia MA; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States.

Publikováno v: Frontiers in allergy [Front Allergy] 2023 Jul 04; Vol. 4, pp. 1126012. Date of Electronic Publication: 2023 Jul 04 (Print Publication: 2023).

How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity.

Autor: Chirra M; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.; Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Newton HS; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Gawali VS; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Wise-Draper TM; Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Chimote AA; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Conforti L; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.

Publikováno v: Cancers [Cancers (Basel)] 2022 Jul 22; Vol. 14 (15). Date of Electronic Publication: 2022 Jul 22.

Immune Checkpoint Inhibitors Regulate K ⁺ Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients.

Autor: Gawali VS; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Chimote AA; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Newton HS; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Feria-Garzón MG; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Chirra M; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Janssen EM; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.; Immunology, Janssen Research and Development, Spring House, PA, United States., Wise-Draper TM; Department of Internal Medicine, Division of Hematology Oncology, University of Cincinnati, Cincinnati, OH, United States., Conforti L; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2021 Aug 27; Vol. 12, pp. 742862. Date of Electronic Publication: 2021 Aug 27 (Print Publication: 2021).

Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma.

Autor: Fu, Ling-ling^1,2 (AUTHOR), Yan, Ming^1,2 (AUTHOR), Yu, Xin¹ (AUTHOR), Shao, Min¹ (AUTHOR), Gosau, Martin² (AUTHOR), Friedrich, Reinhard E.² (AUTHOR), Vollkommer, Tobias² (AUTHOR), Smeets, Ralf^2,3 (AUTHOR), Feng, Hong-chao¹ (AUTHOR) hongchao_feng@sina.com, Xu, Liya¹ (AUTHOR) 22813272@qq.com

Publikováno v: BMC Cancer. 10/15/2024, Vol. 24 Issue 1, p1-13. 13p.